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Hexachlorobenzene (HCB) is a widespread environmental
pollutant. Chronic exposure of humans to HCB produces
a number of effects, such as triggering of porphyria, increased
synthesis of liver microsomal enzymes, neurological symptoms,
immunological disorders and thyroid dysfunctions. In rats, HCB
induced hepatic porphyria, neurotoxic effects, and toxic effects on
the reproductive system, thyroid function, and immune system.
HCB is also known to cause tumors of the liver, thyroid and
mammary gland in laboratory animals. The aim of this study was
to investigate parameters of thyroid growth regulation, mainly cell
proliferation and apoptosis in thyroid tissue from HCB (0.1, 1, 10,
100, and 500 mg/kg body weight)–treated female Wistar rats. The
current study demonstrates that only the exposure to the highest
HCB dose for 30 days, has adverse effects on thyroid endpoints
examined related to thyroid gland morphology, and 3,3#5,5#-
tetraiodothyronine (T4, thyroxine) serum levels, without changes
in thyroid-stimulating hormone concentrations or in thyroid gland
weight. Morphological changes, included flattened epithelium and
increased colloid size compared with control tissue. Transforming
growth factor (TGF-b1) mRNA levels, evaluated by RT-PCR,
revealed a significant upregulation after exposure to HCB (1, 10,
100 mg/kg body weight). Cell proliferation evaluated by 5#-Br
deoxiuridine incorporation into DNA, was not altered at any dose.
HCB (1, 10, 100 mg/kg body weight) induces apoptosis, evaluated
by in situ end labeling of fragmented DNA, terminal deoxy-
nucleotidyl transferase-mediated deoxy uridine triphosphate nick-
end labeling, in rat thyroid glands. This process is associated with
dose-dependent increases in cytochrome c release from the
mitochondria and procaspase-9 processing to its active product.
Caspase-8 was not activated. These studies indicate that doses of
HCB that do not disrupt thyroid economy induce TGF-b1
expression and apoptosis in the thyroid gland, involving the
mitochondrial pathway.
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Hexachlorobenzene (HCB) is a persistent environmental
pollutant with toxic effects in humans and laboratory animals.
Although the use of HCB was discontinued in most countries in
1970#s, it is still released into the environment as a byproduct in
several industrial processes. Alterations in thyroid metabolism
and a risk excess of thyroid cancer have been reported in human
populations exposed to organochlorinated compound mixtures
with a high content of HCB (Grimalt et al., 1994; Meeker et al.,
2007). Increased incidence of goiter was noted two to three
decades later among survivors of Turkish people after accidental
ingestion of grain contaminated with HCB (Peters et al., 1987).
Exposure of various strains of rats to high doses of HCB (1000
mg/kg body weight) causes hypothyroxinemia by elevated
excretion of thyroxine (T4) into bile after the induction of
T4-uridine diphosphate glucuronosyltransferase-1 (UDPGT1)
(Alvarez et al., 2005; van Raaij et al., 1993). In some instances,
these effects are accompanied by compensatory increases in
thyroid weight and circulating levels of thyroid-stimulating
hormone (TSH) (Alvarez et al., 2005; Kleiman de Pisarev et al.,
1989; Rozman et al., 1986; van Raaij et al., 1993). HCB is
a thyroid carcinogen in hamsters (Cabral and Shubik, 1986) and
acts as a tumor promoter of rat liver foci growth (Gustafson
et al., 2000; Ou et al., 2001) and rat mammary tumors (Randi
et al., 2006). It is thought that nongenotoxic carcinogens act by
interfering with molecules intimately involved in cell growth
and cell death. Although many of the mechanisms of thyroid
toxicity have been studied, little is known of the effects of HCB
on thyroid-follicular cell proliferation, a measure of thyroid
gland growth. Normal cell division in the thyroid seems to be
affected by an interplay among several mitogenic factors namely
TSH, insulin-like growth factor-1, insulin, epidermal growth
factor (EGF), and transforming growth factor b1 (TGF-b1).
TGF-b1 is the prototype of a large family of cytokines that
regulate a wide variety of cellular processes including cell
proliferation, cell differentiation, cell motility, apoptosis and
extracellular matrix production (Khosla et al., 1994). TGF-b
responses can be cell-type specific and are dependent on the
activity of other signal transduction pathways, which can either
synergize with or antagonize the TGF-b pathway (Massagué
et al., 2000). It has been shown that UDPGT-inducing chemicals
may increase the expression of TGF-b1 and apoptosis in the
thyroid (Kolaja et al., 1999).
Programmed cell death or apoptosis is an important cellular
process that eliminates unwanted cells during normal
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development or damaged cells after exposure to toxic
chemicals (Lee et al., 2003). There are two major pathways
through which apoptosis are induced; one involves extrinsic
death [TNF/Fas (CD95)] receptors signaling pathway and is
exemplified by caspase-8 activation. Active caspase-8 may
induce apoptosis either directly following activation of
caspase-3 or indirectly following cleavage of cytosolic factors,
such as Bid, leading to involvement of mitochondria.
Another pathway is commonly associated with cytotoxic
agents, radiation, increased reactive oxygen species (ROS) and
growth factor withdrawal and involves cytochrome c release
into the cytosol (Jiang and Wang, 2000). When present in the
cytoplasm, cytochrome c interacts with apoptotic activator
factor-1 (Apaf-1) and, in concert with the initiator caspase-9,
forms the apoptosome. Caspase-9 is then activated at this
complex and triggers the caspase cascade and subsequent
apoptosis (Cain, 2003). Both pathways converge on caspase-3,
-6, and -7 activation, resulting in nuclear degradation and
cellular morphological change.
To our knowledge, the effect of HCB on thyroid-follicular
cell proliferation and apoptosis has not been reported. In
normal thyroid tissue total cell mass is maintained by a balance
between cell proliferation and apoptosis. In this study, we
hypothesize that HCB, an UDPGT inducer, will increase TGF-
b1 expression in the thyroid. Increases in TGF-b1, we further
hypothesize, will induce apoptosis. The objectives of the
present investigation were to examine parameters of thyroid
growth regulation, cell proliferation and apoptosis, in thyroid
tissue from HCB-treated rats. We sought to identify the
apoptosis pathway involved.
MATERIALS AND METHODS
Reagents. HCB (> 99% purity, commercial grade) was purchased from
Aldrich-Chemie GmbH & Co, Steinheim, Germany. Methimazole (MMI) was
a gift of Gador Laboratories, Argentina. Polyvinylidene difluoride (PVDF)
membranes were obtained from Bio-Rad Laboratories, Inc. (Hercules, CA).
Anti-caspase-9 rabbit polyclonal antibody was from Cell Signaling Technol-
ogy, Inc. (Danvers, MA); anti-caspase-8 mouse monoclonal antibody was from
Santa Cruz Biotechnology (Santa Cruz, CA); anti-cytochrome c mouse
monoclonal antibody was obtained from (BD Biosciences, San Jose, CA);
anti-b-actin mouse monoclonal antibody was from Sigma-Aldrich (St Louis,
MO); anti-digoxigenine and monoclonal 5-Bromo-2-deoxiuridine (BrdU)
antibodies were from Biogenex (San Ramon, CA). TGF-b1 primer was
obtained from Invitrogen Life Technology (Carlsbad, CA). The random primers
were obtained from Biodynamics, Argentina. Enzymes and cofactors for
reverse transcription (RT) and PCR were purchased from Promega Corporation
(Madison, WI). All reagents used were of analytical grade.
Animals and treatment. Female Wistar rats (160–180 g at the start of the
experiment) were purchased from the School of Pharmacy and Biochemistry,
University of Buenos Aires, Argentina. The rats were fed Diet 3 rat chow
(Asociación Cooperativas Argentinas, División Nutrición Animal) and water
ad libitum. Environmental conditions consisted of a 12-h light/12-h dark cycle,
temperature 20–24C, and 45–75% humidity. Following a 7-day acclimation
period, HCB was administered daily by gavage for 5 days of each week during
4 weeks, at doses of 0.1, 1, 10, 100, and 500 mg/kg body weight, as indicated
in the text. HCB was administered as a suspension in water, containing Tween
20 (0.5/100 ml). Control animals received equal volumes of the solvent by the
same route. The lowest dose used (0.1 mg/kg body weight) did not disrupt
thyroid hormone metabolism, or malic enzyme activity, a thyroid hormone
responsive liver enzyme, as we have previously demonstrated (Kleiman de
Pisarev et al., 1989, 1990). The maximum dose of HCB employed (500 mg/kg
body weight) altered thyroid hormone metabolism in experiments involving up
to 30 days of intoxication (Kleiman de Pisarev et al., 1995).
MMI, a goitrogeneous product, was used as a positive control for cell
proliferation. MMI (10 mg per rat) was administered by daily ip injections for
30 days. The general health of the animals was not affected by the doses of
HCB employed, as evaluated by the behavior and appearance of the rats,
including examination of the coat, mucous membranes, and body weights, and
their food and water consumption. On the day following the final dose, blood
was obtained, and serum was collected by centrifugation (3000 3 g for
15 min), aliquoted and frozen at 80C until analysis. Body weight and wet
weight of the excised thyroid lobes were recorded. All experiments were
performed in compliance with institutional and international guidelines for
laboratory animal care.
Biochemical determinations. Concentrations of plasma thyroid hormones
were determined in duplicate by RIA using commercially available kits for
tri-iodothyronine (T3) and T4, Eleccys (Electro Chemiluminescence reactions).
TSH was measured according to the RIA kit and the procedure for rat TSH
provided by the National Pituitary Agency. Values were expressed as
arithmetical mean ± SEM (ng/dl for T3, lg/dl for T4 and ng/ml for TSH).
Thyroid gland histomorphology. A portion of the trachea, with intact
thyroid gland attached, was dissected free of connective tissue and fixed in
phosphate buffered saline (PBS), containing 10% neutral formalin, for more
than 24 h, dehydrated in ethanol and embedded in paraffin. Sections of thyroid
glands, 5 lm thick, were cut parallel to the longitudinal axis of the trachea and
stained with hematoxilin-eosin or Periodic-Schiff acid (PAS) for the
morphologycal studies. A subset of 200 follicles from the thyroids of three
rats, were selected for parametric measures of follicle morphology and analyzed
at a magnification of 3400. The morphometric measurements were performed
using digitalized images obtained directly from the light microscope via a video
camera. Measurements were processed using Image-Pro Plus v4.5-Media
(Cybernetics, Inc., Silver Spring, MD). Once selected, the follicular colloid
longest and shortest axes were automatically calculated for every complete
follicle cross section visible in a digital image. Epithelial height was estimated
according to Wade et al. (2002). Follicle colloid area was identified for the
follicles that had no evidence of any artifactual distortion in each image and
was calculated according to Behrends et al. (2005).
Assessment of thyroid-follicular cell proliferation. Thirty minutes prior
to sacrifice, the animals were given an intraperitoneal injection of a solution
(5 mg/ml) of BrdU in saline solution at a dose of 0.08 mg BrdU/g body weight.
BrdU incorporation was stained in tissue sections by an indirect immunohis-
tochemical technique. Briefly, the histological sections mounted on silane-
coated slides were dewaxed and incubated in methanol–hydrogen peroxide
(100:1) for 30 min to inhibit the activity of endogenous peroxidase. Antigen
retrieval was performed in a microwave oven with citrate buffer, pH 6.
Nonspecific blocking was performed by washing in 0.5M Tris–saline buffer,
0.3% bovine albumin. The sections were incubated with the mouse anti-BrdU
antibody (1:40), and washed with the same buffer. Afterward they were
incubated at room temperature for 1 h in a moist chamber with the second
biotinylated antibody (1:200), antimouse IgG (Multilink, Biogenex). Finally,
the sections were incubated in the same conditions with the streptavidin-
peroxidase complex. Horseradish peroxidase was visualized with
3,3#-diaminobenzidine (DAB) (Sigma Chemical Co.). Sections were then
counterstained using PAS and hematoxylin. As negative controls, adjacent
sections were processed omitting incubation with the primary antibody. A dark
brown precipitate indicated the presence of BrdU. The labeling index (LI) was
calculated as the number of labeled cells with BrdU over the total number of
cells in the selected area (magnification: 3400), employing an image analysis
software developed ad hoc to distinguish between positive nuclei (with DAB
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deposits) and hematoxylin stained nuclei. Two to five fields were evaluated for
each category. One thousand nuclei (labeled plus unlabeled) of each thyroid
gland were counted.
Detection of apoptosis. Apoptotic nuclei in tissue sections of thyroid
glands were identified by detection of the DNA breaks with the terminal
deoxynucleotidyl transferase-mediated deoxy uridine triphosphate nick-end
labeling technique (TUNEL). In brief, the paraffin-embedded tissue sections
were deparaffinized by xylene and ethanol. Sections were then incubated with
20 lg/ml proteinase K in PBS, for digesting protein in tissue, followed by
quenching of endogenous peroxidase with 3% H2O2 in PBS. Next,
digoxigenin-dUTP was added to the 3#-OH ends of DNA fragments by the
enzyme terminal deoxynucleotidyl transferase (TdT). After incubating with
anti-digoxigenin antibody conjugated with horseradish peroxidase, the sections
were stained with hydrogen-peroxidase-activated DAB and counterstained with
methyl-green. The mean percentage of positive staining of nuclei was
calculated after counting positively or negatively stained nuclei of 1000
thyrocytes in several fields under light microscope. For negative controls we
performed TUNEL method by the omission of the TdT reaction step. The
apoptotic index was determined as the percentage of apoptotic cells in the total
number of follicular nuclei observed. Image-Pro Plus v4.5 (Media Cybernetics
Inc., Silver Spring, MD) software was used for image capturing and cell
counting. Photographic figures show a representative section of part of one field
of view.
Subcellular fractionation. Thyroids were removed, weighed and imme-
diately homogenized in a Dounce-type glass homogenizer with a Teflon pestle,
in three volumes of homogenization buffer (0.32M sucrose, 1mM ethyl-
enediaminetetraacetic acid in 10mM Tris-HCl pH 7.4). Homogenates were used
for preparation of mitochondria and cytosol. Homogenates were centrifuged at
1300 3 g for 10 min. The supernatant layer was centrifuged at 14,000 3 g for
15 min to yield a crude mitochondrial pellet and a supernatant layer. The
resulting supernantant fraction was used for the assay of cytosolic proteins.
Protein concentration was determined according to Bradford (1976), using
bovine serum albumin (BSA) as a standard.
Western blotting. Rat thyroid cytosolic fraction adjusted protein concen-
tration (50 lg/lane), were electrophoresed in 12% sodium dodecyl sulfate–
polyacrylamide gels and then transferred to PVDF membranes. The blots were
blocked for overnight in TBST (10mM Tris, pH 8.0, 150mM NaCl, 0.05%
vol/vol Tween 20) containing 2% nonfat dry milk and 2% BSA. Blocked
membranes were incubated with anti-caspase-9 rabbit polyclonal antibody
(1:500), anti-caspase-8 mouse monoclonal antibody (1:500), anti-cytochrome c
mouse monoclonal antibody (1:1000), anti-b-actin (1:2000) in TBST overnight
at 4C. The membranes were washed with TBST and incubated with the
suitable horseradish peroxidase-conjugated anti-species-specific antibody
(1:1000) in TBST. Immunoblots were then washed five times with TBST
and once with TBS. Proteins were visualized employing the enzyme-linked
enhanced chemoluminescence kit (Amersham Biosciences, Inc., UK) and
quantified by scanning laser densitometry in a Fotodyne (Foto/Analyst),
Gel-Pro Analyzer 3.1.
RT-PCR analysis of TGF-b1 mRNA. The thyroids were dissected out
and were frozen and stored at 80C prior to RNA extraction. An aliquot of
2lg of total RNA was used to synthesize first-strand cDNA with the random
primer, deoxynuclotide triphosphates, transcriptase reverse, and transcriptase
reverse buffer. The RT mixture (1 ll) was amplified with hot starting PCR in
a 50-ll reaction using GoTaq DNA polymerase (Promega Corporation) for
TGF-b1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
a control to correct for differences between lanes in the amount of RNA.
PCR was performed as follows: reaction mixture for TGF-b1 amplification
was incubated at 94C for 5 min and then amplified at 94C for 1 min, 60C
for 1 min, and 72C for 1 min. Reactions were repeated for 40 cycles.
Reaction mixture for GAPDH amplification was incubated at 94C for 5 min
and then amplified at 94C for 1 min, 55C for 1 min, and 72C for 1 min.
Reactions were repeated for 27 cycles. The PCR mixture (50 ll) contained
GoTaq reaction buffer with 1.5mM MgCl2, 0.2mM dNTP’s mix, 1.25 U
GoTaq DNA polimerase (Promega Corporation), 0.5lM each forward and
reverse primer, and 0.5 ll of RT products. PCR products were detected as
a single band on 2% agarose gel, containing 0.05% vol/vol ethidium bromide.
Bands were detected by Fotodyne (Foto/Analyst) equipment, and intensity
was quantified by scanning laser densitometry in a Fotodyne (Foto/Analyst),
Gel-Pro Analyzer 3.1.
Statistical analysis. Results are presented as mean ± SEM. Differences
between treated and control animals were analyzed by one-way ANOVA at
a 95% confidence interval, followed by Tukey post hoc test to identify
significant differences between samples and their respective controls, after
testing homogeneity of variance using Barlett’s procedure, as described in each
legend. Differences between control and treated animals were considered
significant when p values were < 0.05.
RESULTS
Effect of HCB on Serum Total T4, T3, TSH, and Thyroid
Weight/Body Weight Ratio
In the present study, thyroid endpoints (thyroid weights and
serum hormone concentrations) have been evaluated for their
utility in detecting thyroid-modulating effects after 30 days of
treatment with HCB (1, 10, 100, and 500 mg/kg body weight).
Serum total T4 was reduced 30% in rats treated with HCB
(500). In contrast, treatment of rats with lower doses of HCB
did not affect total T4 after 30 days of treatment. T3 serum
levels were not altered at any dose. No differences in serum
TSH were observed at any dose of HCB. The thyroid relative
weight, thyroid weight (mg)/body weight (g) x 100 (TW/BW),
was not increased by HCB (Table 1). A positive control for
increased serum TSH levels was included, treating rats with the
goitrogeneous agent MMI for 30 days. In all animals, MMI
administration elicited a significant increase in TSH serum
levels and at the same time the TW/BW of the thyroid glands
was increased.
TABLE 1
Dose Response to HCB Administration on Serum Total T4, T3,
TSH, and TW/BW Ratio
T4 (lg/dl) T3 (ng/dl) TSH (ng/ml) TW/BW
Control 3.67 ± 0.52 77.00 ± 5.00 1.83 ± 0.27 8.16 ± 0.30
HCB 1 3.55 ± 0.43 69.00 ± 7.00 2.01 ± 0.32 8.90 ± 0.45
HCB 10 3.88 ± 0.36 75.00 ± 3.00 2.08 ± 0.42 8.49 ± 0.48
HCB 100 3.32 ± 0.29 66.00 ± 5.00 1.89 ± 0.36 9.06 ± 0.52
HCB 500 2.21 ± 0.19* 73.00 ± 6.00 1.93 ± 0.29 8.96 ± 0.41
MMI ND ND 4.65 ± 0.17* 18.6 ± 0.75*
Note. The effect of HCB administration (1, 10, 100, and 500 mg/kg body
weight) on serum total T4, T3, TSH, and thyroid weight/body weight ratio were
measured at 30 days. T4, T3, and TSH serum levels were estimated as described
in ‘‘Materials and Methods.’’ The values are mean ± SEM (n ¼ 4). TW/BW
[thyroid weight (mg)/body weight (g) 3 100]. (ND): not determined.
*Significantly different from control rats (p < 0.05). Statistical comparisons
were made by analysis of variance (one-way ANOVA), with a 95% confidence
interval followed by Tukey post hoc test to identify significant differences
between mean values and indicated control.
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Thyroid Gland Histomorphology
Direct measurements of colloid area and the epithelial
height, provide information on structures involved in thyroid
hormone synthesis, storage and secretion, and also on changes
at the morphological and functional levels. Thyroids from
vehicle treated rats (Fig. 1A) depict the normal thyroid
architecture. Control follicles are oval shaped containing
colloid of uniform color surrounded by orderly cuboidal
epithelium. The epithelium of some larger follicles was
flattened cuboidal to squamous. Examination of histological
sections revealed that the size of the follicles was not at all
homogeneous. Large follicles were located mainly on the outer
edge of some glands. Our results show that only the highest
dose of HCB (500 mg/kg body weight) caused a significant
increase in the colloid area and a decrease in the epithelial
height relative to control (Figs. 1B and 1C). Thus, morphofunc-
tional characteristics of the thyroid gland, in HCB (500 mg/kg
body weight), suggest the organ hypofunction. Animals
exposed to lower doses of HCB did not show alterations
neither in the colloid area nor in the heights of the follicular
epithelium. The size of a follicle depends on the number of
cells and the amount of colloid. These are interchangeable and
vary according to biological activity. MMI-treatment induced
hypertrophy of the thyroid-follicular cells (Fig. 1A, f).
Follicular lumens were narrow, irregular and depleted of
colloid and they were surrounded by a columnar epithelium.
Expression of TGF-b1 in Thyroids of HCB-Treated Rats
As TGF-b1 is increased by UDPGT inducers, we evaluated
TGF-b1 thyroid mRNA levels in HCB-treated rats. The RT-
PCR measurements revealed a significant upregulation of
the mRNA content of TGF-b1 after exposure to HCB (1, 10,
100 mg/kg body weight) for 30 days (Fig. 2). As the lowest
dose used in these experiments (HCB 1 mg/kg body weight)
increased TGF-b1 expression, we have also included a lower
dose (HCB 0.1 mg/kg body weight) that did not alter this
parameter. HCB (500 mg/kg body weight) has not been
included in this and the next experiments, with the purpose of
excluding HCB doses that disrupt thyroid economy.
GAPDH mRNA was used as a loading control.
Effect of HCB on Thyroid-Follicular Cell Proliferation
In order to study the effect of HCB on thyroid-follicular cell
proliferation, we evaluated BrdU incorporation into DNA of
replicative thyroid-follicular cells at doses of HCB (0.1, 1, 10,
100 mg/kg body weight) that did not disrupt thyroid economy
and morphology. The LI was not affected in rats treated with
HCB at any dose. As expected, treatment with MMI induced
a remarkable increase in thyroid-follicular cell proliferation
(Fig. 3B). Proliferating cell nuclear antigen (PCNA) was also
evaluated as a marker of cell proliferation. HCB did not
produce any difference with respect to control animals in
PCNA labeling (data not shown).
In Situ Detection of DNA Fragmentation
Induction of apoptosis was detected by immunohistochem-
ical detection of fragmented DNA (TUNEL) in response to
HCB treatment. In normal thyroid glands, apoptotic nuclei
were rarely found (< 4%) (Fig. 4). Treatment with HCB
increased the incidence of apoptosis, indicated as brown-
FIG. 1. Thyroid gland morphology. (A) Photomicrographs of representative sections identified in rat thyroids at the end of 30 days of treatment with HCB. (a)
Control; (b) HCB 1 mg/kg body weight; (c) 10 mg/kg body weight; (d) 100 mg/kg body weight; (e) 500 mg/kg body weight, and (f) MMI. Colloid in the follicular
lumen is denoted by ‘‘C.’’ The arrow indicates the thyroid epithelium. Bar ¼ 30 lm. Magnification 3400. (B) Quantification of changes in thyroid gland by
measuring the colloid area and the heights of the follicular epithelium. Values are mean ± SEM of 200 follicles from three rats per group. ** and ***Significantly
different from control rats (p < 0.01 and p < 0.001). Statistical comparisons were made by analysis of variance (one-way ANOVA), with a 95% confidence interval
followed by Tukey post hoc test to identify significant differences between mean values and indicated controls. The experiment was repeated twice with similar
results.
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stained apoptotic thyrocytes. The mean percentage of apoptotic
thyrocytes increased (450, 375, and 200%) in HCB (1, 10, and
100 mg/kg body weight) treated rats respectively compared
with control thyroids (Fig. 4B). It must be underlined that the
apoptotic process did not involve one entire follicle at once, but
only some cells. No difference was observed in the wet weight
of thyroid glands between TUNEL-positive and -negative
groups.
HCB-Initiated Mitochondrial Events
In order to investigate if the increase in the apoptotic nuclei
occurs downstream of a possible damage to mitochondria, we
analyzed the release of cytochrome c after 30 days of treatment
with different concentrations of HCB (0.1, 1, 10, and 100 mg/kg
body weight). As shown in Figure 5, HCB induced a dose-
dependent increase of cytochrome c in the cytosol. This increase
was enhanced by 88, 213, and 239% after HCB (1, 10, and
100 mg/kg body weight), respectively.
HCB-Enhanced Cleavage of Procaspase-9
To explore if caspase-9 is activated as a consequence of
cytochrome c release into the cytosol, in response to HCB
treatment, we documented caspase-9 proteolytic processing of
full-length protein. When apoptosis was induced at HCB (1,
10, and 100), caspase-9 was processed in a dose-dependent
manner to yield fragments of ~17 kDa (p17) corresponding to
the active form. The antibody does not recognize full-length
caspase-9 of 51 kDa. As shown in Figure 6, active caspase-9
was increased by 192, 270, and 296% after HCB treatment
(1, 10, and 100 mg/kg body weight), respectively.
HCB Did Not Enhance Cleavage of Procaspase-8
As caspase-8 has been known to be able to release
cytochrome c from mitochondria, we examined if the
proteolitic processing of caspase-8 was activated in thyroids
of HCB (0.1, 1, 10, and 100)–treated rats. Our results show that
procaspase-8 was present primarily as a 53- to 55-kDa protein,
and the active form as a 18-kDa protein. By immunoblotting,
we documented that HCB did not affect the processing of
caspase-8 at any dose (Fig. 7).
DISCUSSION
The daily rates of exposure of the vast majority of the
population for HCB, are lower than the WHO tolerable daily
intake, for noncancer effects and for neoplastic effects in
humans, and are well below the doses used in most
experimental studies (Falcó et al., 2008). In the present study,
we found that serum HCB concentration in the highest dose
group (500 mg/kg) was 600 ng/ml (results not shown).
Analysis of serum samples from 100 subjects of a general
population highly exposed to airborne HCB, revealed HCB
concentrations ranging between 1.1 and 953 ng/ml (To-
Figueras et al, 1997). These observations suggest that the
doses used in the present study, are relevant to human
exposures in highly contaminated populations.
TSH is a well-known growth stimulator of benign goiter and
thyroid cancer, however it possibly does not play any particular
role in organochlorinated-related thyroid growth in human
adults, as results from no increase of TSH level with increasing
polychlorinated biphenyls (PCBs) and HCB levels (Rádiková
et al., 2008; Sala et al., 2001).
The current study demonstrates that subchronic exposure to
HCB (500 mg/kg) causes reductions in circulating T4 levels,
without a compensatory increase in plasma TSH, after 30 days
of treatment, indicating that thyroid homeostasis was signifi-
cantly altered at this dose. Interestingly, other authors reported
that TSH concentrations were increased three-fold at week 2,
declining to near control values at week 19, in a study on
promotion of thyroid tumors in rats by Pregnenolone-16
-carbonitrile (Vansell et al, 2004). We do not think that in the
present study, TSH levels would have increased earlier,
returning to its control level at 30 days, because we have
previously demonstrated that shorter times of HCB (1000 mg/kg)
administration did not modify TSH levels (Kleiman de Pisarev
FIG. 2. Analysis of TGF-b1 expression in thyroid glands from HCB-
treated rats. Rats were treated with HCB (0.1, 1, 10, and 100 mg/kg body
weight) for 30 days. (A) Representative pattern of RT-PCR amplification of
both control cDNA and HCB (0.1, 1, 10, and 100 mg/kg body weight) cDNA,
synthesized from total RNA. GAPDH was used as a loading control. (B)
Quantification of cDNAs, after correction with GAPDH cDNA. Ethidium
bromide stained gels were photographed, scanned and the band intensities
determined. The values are mean ± SEM of two independent experiments of
three rats per group. *Significantly different from control rats (p < 0.05).
Statistical comparisons were made by analysis of variance (one-way ANOVA),
with a 95% confidence interval followed by Tukey post hoc test to identify
significant differences between mean values and indicated controls.
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et al., 1989). On this respect we have reported that there is
a discrepancy between the ability of HCB to reduce circulating
levels of T4 and its ability to produce a functional shift in liver
thyroid status (Kleiman de Pisarev et al., 1995). It is well
known that increased rate of intrapituitary T4 to T3 conversion
by deiodinase type II results in inhibition of TSH release,
although, vice versa, TSH release is stimulated by decreased
rate of such conversion. Thus, it is possible that type II
deiodinase activity is upregulated in the pituitary, in response
to HCB 500 mg/kg induced hypothyroxinemia.
Morphometric measurements may be helpful in characteriz-
ing early and/or transient responses to toxicants that have
multiple disrupting effects. Our results show that frank
alterations in the gland histomorphology and reductions in
circulating T4 are only apparent in animals exposed to HCB
(500 mg/kg) dose, suggesting a hypfunctioning gland.
In the present study we have shown that HCB doses that do
not disrupt thyroid hormone economy or thyroid morphology,
did not alter thyroid-follicular cell proliferation evaluated by
BrdU incorporation and PCNA-labeled nuclei. On this respect
it has been reported that microsomal enzyme inducers that do
not increase serum TSH, that is, 3-methylcholantrene and
Aroclor 1254 (PCB), do not increase thyroid-follicular cell
proliferation (Klaassen and Hood, 2001).
FIG. 3. Effect of HCB on thyroid-follicular cell proliferation. Rats were treated with HCB (0.1, 1, 10, and 100 mg/kg body weight) for 30 days. Cell
proliferation was evaluated by BrdU incorporation into DNA of replicative thyroid-follicular cells. (A) Thyroid-follicular cell nuclei labeled with BrdU are
indicated with an arrow. Magnification 3400. (B) LI, number of labeled cells with BrdU over the total number of cells. Each value represents the mean ± SEM
(n ¼ 1000 nuclei per rat) from three rats per group. ***Significantly different from control rats (p < 0.001). Statistical comparisons were made by analysis of
variance (one-way ANOVA), with a 95% confidence interval followed by Tukey post hoc test to identify significant differences between mean values and indicated
controls. The experiment was repeated twice with similar results.
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Iodine and TGF-b are the only known negative regulators of
thyroid cell number. To control epithelial cell number, TGF-b
acts through two independent pathways. First, it inhibits
proliferation through Smad-dependent c-myc repression,
depending on the cell type. Second, in some cell types TGF-b
has been shown to induce apoptosis (Chen et al., 2002).
In this study we demonstrate for the first time that HCB,
a UDPGT inducer, increases TGF-b1 gene expression in the
rat thyroid follicular cells, in the absence of an increase of
endogenous TSH. Given the relationship between HCB and
the increase in TGF-b1 expression, we hypothesized that
thyroid apoptosis might also be increased. In the current study
we demonstrate that thyroid-follicular cells are sensitive to the
apoptotic inducing effect of HCB, at all assayed doses,
although the increase is less pronounced at 100 mg/kg.
However the apoptotic effect is still remarkable at this dose,
as shown by the high percentage of apoptotic cells (200%). In
a similar manner, the goitrogenic compound propylthiuracil
FIG. 4. Detection of in situ DNA breaks by TUNEL staining. (A) TUNEL staining of thyroid-follicular cells from control and HCB-treated rats. (a) Control,
(b) 0.1, (c) 1, (d) 10, and (e) 100 mg/kg body weight. Magnification 3600. Arrows point to brown-stained apoptotic cells. (B) Values represent the mean ± SEM of
TUNEL-positive cells (n ¼ 1000 cells per rat) from two independent experiments of three rats per group. ** and ***Significantly different from control rats (p <
0.01 and p < 0.001). Statistical comparisons were made by analysis of variance (one-way ANOVA), with a 95% confidence interval followed by Tukey post hoc
test to identify significant differences between mean values and indicated controls.
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increased thyroid-follicular cell proliferation, the expression
of TGF-b1 and apoptosis in the thyroid (Kolaja et al., 1999).
It has also been demonstrated that in cultured porcine thyroid-
follicular cells, TGF-b1 induces apoptosis (Bechtner et al.,
1999). The doses of HCB causing significant increases in
TGF-b1 expression and apoptosis, suggest that HCB can
affect these parameters by direct actions on the gland rather
than by producing a disruption in thyroid hormone homeo-
stasis. High levels of TGF-b expression has also been
associated to a counter-regulatory mechanism to prevent
tumor growth (Derwahl and Studer, 2002). On this respect, it
has been demonstrated that in a human medullary thyroid
carcinoma cell line, TGF-b1 treatment decreases cell pro-
liferation and increases the rate of cell death (Khosla et al.,
1994). It has been demonstrated that HCB can induce alveolar
adenomas of the thyroid in Syrian male golden hamsters fed
4, 8 or 16 mg/kg body weight per day of HCB (Cabral and
Shubik, 1986; Cabral et al., 1977). The results of the present
study, may be relevant to the molecular events involved in
HCB tumor promoter activity, because it has been reported
that TGF-b may become a stimulator of proliferation,
invasion, angiogenesis and metastasis (Stover et al., 2007).
It has been proposed that induced TGF-b1 may assist
exaggerated proliferation of certain preneoplastic thyrocytes
that are more resistant to TGF-b1 induced cell death than
surrounding cells (Kolaja et al, 1999). Although our results
are far from establishing a direct connection between the
induction of apoptosis by HCB and human proliferative
thyroid diseases, they provide the groundwork for further
research in this area.
Among most of the numerous proposed hierarchical models
of the caspase cascade, caspase-8, caspase-9, and cytochrome c
are upstream regulatory elements in apoptotic pathways. Our
work demonstrates that HCB induces a significant increase of
cytochrome c in the cytosol, with HCB 10 and 100 mg/kg,
providing evidence that the mitochondrial pathway is involved
in HCB-induced apoptosis. Following release from mitochon-
dria, cytochrome c binds to Apaf-1 resulting in the activation of
caspase-9, which in turn activates the effector caspases
responsible for the cleavage of many of the substrates
associated with the characteristic biochemical and morpholog-
ical changes of apoptosis (Cain, 2003). The enhanced dose-
response cleavage of procaspase-9, reported in the present
study is consistent with the role of caspase-9 in the apoptotic
pathway activated by HCB in thyroid-follicular cells. It is
interesting that this caspase cascade, with caspase-9 at the
apex, is the major pathway initiated in many forms of
chemically induced apoptosis (Sun et al., 1999). It has been demo-
nstrated that apoptosis induced by TGF-b1 is accompanied
FIG. 5. HCB induces cytochrome c release in thyroid-follicular cells. (A)
Immunochemical detection of cytochrome c levels in the cytosolic fraction of
thyroid tissue. Rats were treated with HCB (0.1, 1, 10, and 100 mg/kg body
weight) during 30 days. The release of cytochrome c into the cytoplasm was
detected by Western blotting with anti-cytochrome c antibody. The same
samples were probed with b-actin antibody as a loading control. (B)
Densitometric quantification of cytochrome c content by scanning of the
immunoblots. The levels of cytochrome c are expressed as arbitrary units.
Values are mean ± SEM of three independent experiments of three rats per
group. * and **Significantly different from control rats (p < 0.05 and p < 0.01).
Statistical comparisons were made by analysis of variance (one-way ANOVA),
with a 95% confidence interval followed by Tukey post hoc test to identify
significant differences between mean values and indicated controls.
FIG. 6. Enhanced cleavage of procaspase-9 induced by HCB. (A) Active
caspase-9 was determined by immunoblotting in the cytosolic fraction of
thyroid tissue from HCB (0.1, 1, 10, and 100 mg/kg body weight)–treated rats
during 30 days. The same samples were probed with b-actin antibody as
a loading control. (B) Quantification of cytosolic active caspase-9 by
densitometric scanning of the immunoblots. Values are means ± SEM of three
independent experiments of three rats per group. *Significantly different from
control rats (p < 0.05). Statistical comparisons were made by analysis of
variance (one-way ANOVA), with a 95% confidence interval followed by
Tukey post hoc test to identify significant differences between mean values and
indicated controls.
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with ROS generation. Thus, we could speculate that HCB
induced ROS generation in a dose-dependent manner,
eliciting dose-dependent increases in cytochrome c and
caspase-9 activity (Wang et al., 2008).
Bcl-2 family proteins, including Bax, Bak, and Bcl-Xs for
proapoptosis and Bcl-2, Bcl-XL, and Mcl-1 for antiapoptosis,
have been demonstrated to be involved in the process of
mitochondrial induced apoptosis (Jurgensmeier et al., 1998).
Preliminary studies from our laboratory indicated that the
levels of proapoptotic (Bax) and antiapoptotic (Bcl-2) proteins
were deregulated by HCB treatment (results not shown).
Caspase-8 can be activated by one of several death receptors
when bound by the appropriate ligands, including TNF, FasL,
and TNF-related apoptosis-inducing ligand. It can also be
activated in the absence of a death receptor signal, as has been
demonstrated for drug-induced apoptosis (Wesselborg et al.,
1999) suggesting that other mediators of apoptosis might also
be involved. The results from the present study show that
although caspase-8 was not activated by HCB, we cannot
exclude death receptor-induced apoptosis mediated by the
activation of caspase-3 by caspase-10 as has been described by
Wang et al., (2001), eliciting an increased programmed cell
death at HCB 1 and 10 mg/kg.
There is an apparent discrepancy among TGF-b1 mRNA
expression, induced apoptosis decreasing at the highest HCB
dose (100 mg/kg) and the increasing trend in cytochrome c
levels and caspase-9 activity. Our results suggest that caspase-
dependent and -independent pathways may be operating
together in HCB-induced apoptosis in the thyroid gland. The
possibility exists that the higher TUNEL-positive nuclei at
HCB 1 and 10 mg/kg, when compared with HCB 100 mg/kg,
could be related to induction of other caspases (such as caspase
10) that may potentiate the apoptotic effect. We could also
speculate that a caspase-independent pathway may be also
operating to increase relative apoptotic index at the lower
doses. On that respect, HCB (1 and 10 mg/kg) treatment might
change mitochondrial membrane permeability leading to
release of the apoptotic inducing factor which after entering
nucleus results in increased apoptosis, as recently demonstrated
in HeLa cell lines (Jayaraj et al., 2009). Future experiments
would be necessary to clarify those points.
In summary, these studies indicate for the first time that the
administration of HCB doses that do not disrupt thyroid
economy, induce TGF-b1 expression and apoptosis in the
thyroid gland, involving the mitochondrial pathway. As the
delicate balance between apoptosis and cell proliferation may
play an important role in the control of thyroid gland mass, our
observations provide a clue to a potentially important
mechanism to the molecular events involved in HCB
carcinogenic activity.
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